Molecular Determinants of Head and Neck Cancer (Current Cancer Research) - Image 1

£109.08

Humana Molecular Determinants of Head and Neck Cancer (Current Cancer Research)

Name: Molecular Determinants of Head and Neck Cancer (Current Cancer Research)
Brand: Humana
Price: 109.08 GBP
Availability: InStock

Oncology

This is the most expensive it has ever been. Walk away.

£109 today · previous high £109 · all-time low £109

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 80 days · 80 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 80 days • 1 price levels

Days at Price

Price Analysis

Most common price: £109 (80 days, 100.0%)

Price range: £109 - £109

Price levels: 1 different prices over 80 days

Description

Squamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. It is estimated that approximately 50,000 patients develop head and neck cancer annually in the United States, of whom approximately 50% succumb to this cancer. For most cases of SCCHN, treatment is multimodal, often combining surgery or irradiation with chemotherapy; even successfully treated patients frequently experience durable and severe side effects. Improving cure rates and reducing chronic morbidity are urgent clinical needs for head and neck cancer. However, in contrast to cancer types such as breast or prostate that have been much studied and have well-defined biology, until recently, relatively few researchers investigated the molecular basis of HNC, making it difficult to design targeted treatments with better efficacy and less debilitating side effects. This volume will provide an overview of the factors contributing to disease pathogenesis, including the recognition of discrete molecular subtypes with distinct etiology, prognosis, and treatment response. This volume will familiarize the reader with the critical signaling pathways and oncogenic drivers for HNC. It will outline the differences between HPV-positive and HPV-negative disease, and how these differences affect treatment choice and outcome. The book will emphasize developments in the past five years, including the growing understanding of the genomic and epigenomic features of the disease based on analysis of next generation sequencing (NGS) data, and timely topics such as the analysis of HNC stem cell populations, non-coding mRNAs, and inflammatory response. It will address exciting new therapeutic approaches such as the use of immunotherapies to treat HNC patients. Overall, the book will provide the reader with current understanding of the biology and treatment of the disease, and describe timely questions that will guide future research aimed at controlling and curing this disease.

Product Specifications

Brand: Humana
Format: paperback
ASIN: 3030087794
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 29 December 2018
Listed Since: 28 December 2018

Barcode

No barcode data available

Humana Molecular Determinants of Head and Neck Cancer (Current Cancer Research)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer

Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer

Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)

HPV Infection in Head and Neck Cancer: 206 (Recent Results in Cancer Research, 206)

Critical Issues in Head and Neck Oncology: Key Concepts from the Seventh THNO Meeting

Methods of Cancer Diagnosis, Therapy, and Prognosis: General Overviews, Head and Neck Cancer and Thyroid Cancer: 7

Prognosis in Head and Neck Cancer

Cancer of the Oral Cavity, Pharynx and Larynx: Evidence-Based Decision Making

Oral Cancer Metastasis

Trends in Cervical Cancer

Head and Neck Cancer Imaging (Medical Radiology)

Multidisciplinary Care of the Head and Neck Cancer Patient: 174 (Cancer Treatment and Research, 174)

Radiation Therapy for Head and Neck Cancers: A Case-Based Review

The Papillomaviruses

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)

A Multidisciplinary Approach to Head and Neck Neoplasms (Otolaryng- Head and Neck Surgery)

Management of Castration Resistant Prostate Cancer (Current Clinical Urology)

The Head and Neck Cancer Patient: Neoplasm Management, An Issue of Oral and Maxillofacial Surgery Clinics of North America (Volume 31-1) (The Clinics: Dentistry, Volume 31-1)

Chemokines and Cancer (Contemporary Cancer Research)

Cancer of the Lung: From Molecular Biology to Treatment Guidelines (Current Clinical Oncology)

Cervical Cancer: From Etiology to Prevention: 2 (Cancer Prevention-Cancer Causes, 2)

Human Papillomavirus Vaccines

HPV and Cervical Cancer: Achievements in Prevention and Future Prospects

Nucleic Acid Therapeutics in Cancer (Cancer Drug Discovery and Development)